查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016972

手術機器人市場：按組件、類型、技術和最終用戶分類－2026年至2032年全球市場預測

Surgical Robots Market by Component, Type, Technology, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年手術機器人市場價值為 100.8 億美元，預計到 2026 年將成長至 109.2 億美元，複合年成長率為 9.79%，到 2032 年將達到 193.8 億美元。

主要市場統計數據
基準年 2025 100.8億美元
預計年份：2026年 109.2億美元
預測年份 2032 193.8億美元
複合年成長率 (%) 9.79%

我們認為，手術機器人的引入是一項永續的臨床和商業性革命，它將從根本上改變手術範式和醫療機構的規劃。

手術機器人技術正從一項顛覆性新技術演變為現代外科手術實踐的基礎要素，重塑整個醫療保健體系中手術的規劃、實施和規模化方式。器械、控制軟體和人體工學的進步，以及圍手術全期流程的廣泛變革，正在催生新的手術技術，並拓展受益於更高精度手術的干涉範圍。因此，臨床、製造和保險領域的相關人員正在重新評估關於病例選擇、培訓和資金配置的長期假設。

識別技術、臨床和商業性變革的融合，這些變革正在重新定義手術機器人的競爭優勢和運作模式。

外科機器人領域正經歷一場變革，其驅動力來自於技術成熟和醫療模式重塑等多個相互關聯的趨勢。首先，系統結構的模組化和手術器械的進步正在加速機器人技術的應用，使其不再局限於早期採用者，而是擴展到更廣泛的專科領域。這一趨勢降低了整體整合成本，並使得根據手術量和臨床複雜程度製定分階段部署策略成為可能。

了解 2025 年美國關稅將如何重塑整個外科機器人價值鏈的供應商策略、採購趨勢和投資決策。

美國2025年實施的關稅措施的累積影響正對全球供應鏈、籌資策略以及手術機器人生態系統中的競爭地位產生連鎖反應。關稅壓力促使企業重新評估零件採購、契約製造和最終組裝的地理風險。因此，企業面臨短期利潤率下降與透過供應商多元化和製造能力回流實現長期韌性之間的權衡。

明確組件、臨床應用、技術架構和最終用戶環境等方面的有意義的細分層，以幫助選擇準確的產品市場契合度和打入市場策略。

組件層面的差異化驅動產品架構和售後市場經濟，器械及配件、機器人系統以及軟體和服務各自形成獨特的應用路徑。器械及配件是單次手術經濟效益和快速創新週期的核心，而機器人系統則構成資本投資和營運整合的基礎。軟體和服務將數據和平台連接轉化為持續的收入來源，並改善臨床工作流程。組件之間的這些差異需要製定個人化的商業化和支持策略。

本研究分析了美洲、歐洲、中東和非洲以及亞太地區在臨床、監管和商業方面的區域差異，並指導區域優先事項和資源分配。

區域趨勢反映了臨床生態系統、法律規範和投資環境的差異，影響美洲、歐洲、中東和非洲以及亞太地區的商業化策略。在美洲，擁有集中採購結構和成熟私人醫院網路的醫療保健系統為整合解決方案創造了集中機遇，同時也要求強力的證據和服務承諾。該地區的醫療服務提供者通常尋求可預測的總成本控制方法和擴充性的培訓項目。

該評估旨在評估具有競爭力的領導企業如何整合模組化系統設計、整合服務生態系統和軟體優先方法，以確保長期的臨床和商業性優勢。

目前，外科機器人領域的競爭格局有利於那些將系統專業知識、卓越的服務提案和可擴展的軟體平台結合的企業。主要企業正日益專注於支援第三方儀器生態系統的模組化架構，從而實現功能的快速部署並拓展臨床應用範圍。這種模組化方法降低了專注於特定領域的新進入者的進入門檻，同時也使成熟企業能夠保護其核心系統的價值，並促進合作夥伴的創新。

為製造商和醫療保健系統合作夥伴提供切實可行的策略和營運步驟，以確保強大的供應鏈，加快臨床醫生採用該平台，並實現平台功能的貨幣化。

產業領導企業應優先考慮一系列切實可行的舉措，以平衡商業性目標與營運可行性。首先，投資本地生產並與檢驗的供應商建立合作關係，以降低關稅和供應鏈風險，同時確保品管。其次，將商業模式轉型為混合模式，平衡設備銷售與持續服務和軟體收入，從而降低採用門檻並提高客戶終身價值。第三，透過投資經過檢驗的培訓課程、基於模擬的認證以及與醫療保健系統合作開展結果追蹤，加快臨床醫生採用該技術。

描述了一種混合方法研究方法，該方法結合了臨床訪談、第二手資料的系統檢驗和情境分析，以檢驗策略結論。

本研究將一手定性資料與嚴謹的二手資訊檢驗結合，以確保分析的嚴謹性和可靠性。一手研究包括對外科醫生、採購經理、醫療設備工程師和監管專家進行結構化訪談，以了解他們對臨床效用、營運限制和採購因素的實際觀點。透過這些對話，建構了一個主題框架，並確定了需要進一步分析的高優先級問題。

本文總結了組織將平台創新轉化為永續的臨床部署和長期商業性優勢的基本策略要求。

總之，外科機器人技術正處於一個轉折點，技術成熟度、不斷演進的經營模式和政策轉變在此交匯，為那些佔據有利地位的企業創造了永續的戰略機會。領導者面臨的挑戰顯而易見：將產品開發與模組化架構結合，投資於能夠持續創造價值的服務和軟體能力，並在貿易政策不斷變化的情況下增強價值鏈的韌性。能夠將臨床證據、營運部署和支付方合作整合到一個連貫的商業化計畫中的企業，才能最終取得成功。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 手術機器人市場：依組件分類

  • 設備和配件
  • 機器人系統
  • 軟體服務

第9章 手術機器人市場：按類型分類

  • 通用外科手術機器人
  • 腹腔鏡手術機器人
  • 神經外科機器人
  • 整形外科機器人
  • 泌尿系統機器人

第10章 手術機器人市場：依技術分類

  • 遠端機器人
  • 繫繩/主機型機器人

第11章 手術機器人市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 研究機構
  • 專科診所

第12章 手術機器人市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 手術機器人市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 手術機器人市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國手術機器人市場

第16章：中國手術機器人市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accuray Incorporated
  • AcuSurgical
  • Asensus Surgical US, Inc.
  • avateramedical GmbH
  • Brainlab AG
  • CMR Surgical Ltd.
  • Corin Group
  • Diligent Robotics Inc.
  • eCential Robotics
  • EndoQuest Robotics, Inc.
  • Globus Medical
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services. Inc.
  • KUKA AG by Midea Group
  • Medicaroid Corporation
Product Code: MRR-034B50030934

The Surgical Robots Market was valued at USD 10.08 billion in 2025 and is projected to grow to USD 10.92 billion in 2026, with a CAGR of 9.79%, reaching USD 19.38 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 10.08 billion
Estimated Year [2026] USD 10.92 billion
Forecast Year [2032] USD 19.38 billion
CAGR (%) 9.79%

Framing the strategic context for surgical robotics adoption as a durable clinical and commercial revolution that reshapes procedure paradigms and institutional planning

Surgical robotics is evolving from a disruptive novelty into a foundational element of modern operative practice, reshaping how procedures are planned, executed, and scaled across care settings. Advances in instrumentation, control software, and ergonomics are converging with broader shifts in perioperative pathways, enabling new procedural modalities and expanding the range of interventions that benefit from enhanced precision. As a result, stakeholders across clinical, manufacturing, and payer communities are re-evaluating long-held assumptions about case selection, training, and capital allocation.

This introduction establishes the context for an executive-level assessment of this dynamic sector. It highlights technological inflection points, supply chain resilience considerations, and institutional adoption drivers that inform strategic choices. Importantly, the narrative focuses on structural forces - clinical value proposition, interoperability expectations, and service-oriented commercialization - rather than transient trends. By situating these forces within an operational and strategic framework, leaders can better align investments with long-term clinical and business outcomes.

Throughout this executive summary, emphasis remains on how innovations and policy shifts intersect to create both risk and opportunity. The aim is to equip decision-makers with a clear-eyed perspective that supports informed prioritization, cross-functional alignment, and the design of sustainable competitive advantage in an era of rapid change.

Identifying the convergent technological, clinical, and commercial shifts that are redefining competitive advantage and operational models in surgical robotics

The landscape for surgical robotics is undergoing transformative shifts driven by multiple, mutually reinforcing trends that extend from technology maturation to care model redesign. First, modularity in system architecture and advances in instrumentation are accelerating the migration of robotics into a wider range of specialties beyond early adopters. This trend reduces total cost of integration and enables incremental deployment strategies aligned to procedural volume and clinical complexity.

Second, software-driven workflows, including improved imaging integration and data analytics, are shifting value from hardware sales alone to ongoing service and platform relationships. As a consequence, commercial models are evolving to emphasize lifecycle services, subscription-based software licensing, and performance-based contracting. Third, workforce factors and training innovations are enabling more rapid clinician proficiency through simulation, telementoring, and validated credentialing pathways, thereby lowering the practical barriers to system utilization.

Finally, regulatory and reimbursement environments are adjusting to novel device classifications and digital health intersections. These adjustments influence product development priorities, clinical evidence generation, and payer engagement strategies. Collectively, these shifts create a landscape in which competitive advantage will increasingly derive from integrated offerings that combine robust hardware, adaptable software, and credible ecosystem partnerships that support clinicians across the care continuum.

Understanding how the 2025 United States tariff measures are reshaping supplier strategies, procurement dynamics, and investment choices across the surgical robotics value chain

The cumulative impact of United States tariffs introduced in 2025 has cascading implications for global supply chains, procurement strategies, and competitive positioning in the surgical robotics ecosystem. Tariff pressures incentivize companies to reassess geographic exposure across component sourcing, contract manufacturing, and final assembly. In turn, firms face trade-offs between near-term margin compression and longer-term resilience achieved through supplier diversification or repatriation of manufacturing capabilities.

Because surgical robotics systems combine high-precision mechanical parts, specialty materials, and sophisticated electronics, elevated import costs prompt a rebalancing of supplier portfolios toward partners that can offer vertical integration, local content, or value-added services. Procurement teams are responding by instituting more rigorous total-cost-of-ownership analyses and by negotiating multi-year supplier commitments to secure capacity and mitigate price volatility. Simultaneously, some market participants accelerate investment in domestic production and validation facilities to insulate critical subsystems from cross-border tariff exposure.

On the demand side, hospitals and ambulatory centers are adapting purchasing cycles and financing arrangements to reflect cost uncertainty and operational priorities. Consequently, manufacturers are exploring alternative pricing and financing models that allocate risk and support adoption despite higher entry costs. Transitioning through these dynamics requires a pragmatic balance of supply chain redesign, cost engineering, and stakeholder engagement to preserve clinical access while sustaining profitability.

Clarifying meaningful segmentation layers across component, clinical application, technology architecture, and end-user context to inform precise product-market fit and go-to-market choices

Component-level differentiation drives product architecture and aftermarket economics, with Instruments & Accessories, Robotic Systems, and Software & Services each shaping adoption pathways in distinct ways. Instruments & Accessories are central to per-procedure economics and rapid innovation cycles, whereas Robotic Systems anchor capital deployment and operational integration. Software & Services convert data and platform connectivity into recurring revenue streams and clinical workflow improvements. These component distinctions necessitate tailored commercialization and support strategies.

Type-based segmentation further clarifies clinical adoption contours, spanning General Surgery Robots, Laparoscopic Robots, Neurosurgical Robots, Orthopedic Robots, and Urological Robots. Each procedural domain imposes unique technical requirements, surgeon interface preferences, and evidence thresholds that influence product roadmaps and clinical champions. For example, modalities with high anatomical variability demand advanced imaging integration, while those with repetitive motion patterns benefit most immediately from increased automation.

Technology orientation separates offerings into Telerobotic and Tethered / Console-Based Robots, illustrating divergent development pathways. Telerobotic solutions emphasize connectivity, latency management, and distributed care models, while tethered console-based systems optimize for ergonomic control, haptic feedback, and on-site reliability. End-user segmentation highlights the operational contexts for deployment, with Ambulatory Surgical Centers, Hospitals, Research Institutes, and Specialty Clinics each presenting different procurement cycles, staffing models, and utilization profiles. Understanding the interplay among component, type, technology, and end-user segments enables more precise product-market fit and commercial segmentation strategies.

Interpreting regional clinical, regulatory, and commercial variations across the Americas, Europe Middle East and Africa, and Asia-Pacific to guide geographic prioritization and resource allocation

Regional dynamics reflect varied clinical ecosystems, regulatory frameworks, and investment climates, with implications for commercialization strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, health systems with centralized procurement and established private hospital networks create concentrated opportunities for integrated solutions, while also demanding robust evidence and service commitments. Providers in this region often seek predictable total-cost approaches and scalable training programs.

Across Europe, Middle East & Africa, diverse regulatory regimes and payer structures drive a more fragmented adoption landscape. Manufacturers must navigate country-specific approval pathways, localized reimbursement nuances, and partnerships with regional distributors to achieve penetration. The necessity of tailored clinical evidence and flexible commercial arrangements is particularly acute in these markets due to varied hospital infrastructures and procedural norms.

Asia-Pacific presents both high-growth clinical demand and a spectrum of manufacturing capabilities. Strategic partnerships with regional OEMs, investment in localized support networks, and sensitivity to price-performance expectations can accelerate adoption. Across all regions, an emphasis on post-sale service excellence and clinical training emerges as a universal enabler of sustained utilization, while regional policy shifts and procurement reform continue to influence strategic timing and resource allocation.

Assessing how competitive leaders blend modular system design, integrated service ecosystems, and software-first approaches to secure long-term clinical and commercial advantage

Competitive dynamics in surgical robotics now favor organizations that combine systems expertise with compelling service propositions and extensible software platforms. Leading companies are increasingly focusing on modular architectures that support third-party instrument ecosystems, enabling faster feature rollouts and broader clinical applicability. This modular approach reduces barriers for specialty-focused entrants and allows incumbents to protect core system value while cultivating partner innovation.

Strategic partnerships between device manufacturers, software developers, and clinical networks are also more prevalent, reflecting the importance of integrated solutions that deliver measurable clinical and operational benefits. Companies that build robust clinician training pathways, credentialing programs, and outcome-tracking capabilities gain a commercial edge by shortening the adoption curve and demonstrating sustained value to health systems. Aftermarket services and consumable strategies create predictable revenue streams and deepen customer relationships, which in turn support longer-term retention.

Finally, capital allocation is shifting toward companies that can demonstrate cross-disciplinary competencies-medical device engineering, cloud-enabled software, and regulated data management. Firms that invest in interoperability, secure data architectures, and real-world evidence generation position themselves to capture the platform-level opportunities that will define second-wave competition in surgical robotics.

Practical strategic and operational steps for manufacturers and health system partners to secure resilient supply chains, accelerate clinician adoption, and monetize platform capabilities

Industry leaders should prioritize a set of actionable initiatives that align commercial ambition with operational realism. First, invest in localized manufacturing or validated supplier partnerships to mitigate tariff exposure and supply risk while maintaining quality controls. Second, shift commercial models toward hybrid arrangements that balance capital sales with recurring service and software revenues, thereby reducing adoption friction and improving lifetime customer value. Third, accelerate clinician adoption by investing in validated training curricula, simulation-based credentialing, and outcome-tracking collaborations with health systems.

In parallel, leaders must build robust regulatory and payer engagement capabilities to support evidence generation that aligns with local approval and reimbursement expectations. This includes designing clinical programs that collect meaningful outcome data and demonstrating cost-effectiveness in real-world settings. Additionally, prioritize interoperability and secure data frameworks to enable third-party integrations and to support long-term platform extensibility. From a portfolio perspective, consider modular product roadmaps that allow incremental market entry across surgical specialties and care settings, and deploy scenario planning to stress-test supply chain, pricing, and adoption assumptions.

Finally, cultivate partnerships with academic centers and specialty clinics to co-develop clinical pathways and to accelerate clinical validation. These relationships both build credibility among clinicians and create real-world testbeds for iterative product improvement, ensuring that strategic investments translate into tangible adoption outcomes.

Describing a mixed-methods research approach combining primary clinical interviews, systematic secondary source triangulation, and scenario analysis to validate strategic conclusions

This research synthesis relies on a combination of primary qualitative inputs and rigorous secondary source triangulation to ensure analytical rigor and credibility. Primary research included structured interviews with surgeons, procurement leaders, device engineers, and regulatory specialists to capture frontline perspectives on clinical utility, operational constraints, and procurement drivers. These conversations informed thematic frameworks and identified high-priority questions for further analysis.

Secondary research involved the systematic review of regulatory guidance, peer-reviewed clinical literature, clinical trial registries, procurement policy documents, and industry technical white papers to contextualize primary insights. The analysis employed a triangulation approach, cross-referencing multiple data streams to validate narrative conclusions and to identify consistent patterns across regions and specialty domains. Scenario analysis supplemented the core methodology, exploring plausible outcomes under varying supply chain, tariff, and reimbursement conditions to stress-test strategic recommendations.

Quality controls included expert panel reviews and methodological audits to ensure reproducibility and to mitigate cognitive bias. Data provenance was maintained through documented source trails and clear delineation of primary versus secondary inputs, enabling transparency for purchasers who require deeper methodological interrogation or bespoke extensions of the base study.

Summarizing the strategic imperatives that will enable organizations to convert platform innovation into sustained clinical adoption and durable commercial advantage

In conclusion, surgical robotics stands at an inflection where technological maturity, evolving commercial models, and policy shifts converge to create sustained strategic opportunities for well-positioned organizations. The imperative for leaders is clear: align product development with modular architectures, invest in service and software capabilities that drive recurring value, and shore up supply chain resilience in the face of trade policy volatility. Success will favor those who can integrate clinical evidence, operational deployment, and payer alignment into coherent commercialization plans.

Moving forward, the most impactful initiatives will be those that convert platform potential into measurable clinical and operational outcomes. This requires disciplined prioritization of specialty targets, investment in clinician training and credentialing, and rigorous collection of real-world evidence. By doing so, organizations can accelerate clinician confidence, justify procurement decisions, and sustain adoption across diverse care settings.

Leaders who combine strategic foresight with executional discipline will shape the next chapter of surgical robotics, moving the field from early adoption into widespread, value-driven clinical integration that benefits providers, patients, and commercial stakeholders alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Robots Market, by Component

  • 8.1. Instruments & Accessories
  • 8.2. Robotic Systems
  • 8.3. Software & Services

9. Surgical Robots Market, by Type

  • 9.1. General Surgery Robots
  • 9.2. Laparoscopic Robots
  • 9.3. Neurosurgical Robots
  • 9.4. Orthopedic Robots
  • 9.5. Urological Robots

10. Surgical Robots Market, by Technology

  • 10.1. Telerobotic
  • 10.2. Tethered / Console-Based Robots

11. Surgical Robots Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Research Institutes
  • 11.4. Specialty Clinics

12. Surgical Robots Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Surgical Robots Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Surgical Robots Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Surgical Robots Market

16. China Surgical Robots Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Accuray Incorporated
  • 17.6. AcuSurgical
  • 17.7. Asensus Surgical US, Inc.
  • 17.8. avateramedical GmbH
  • 17.9. Brainlab AG
  • 17.10. CMR Surgical Ltd.
  • 17.11. Corin Group
  • 17.12. Diligent Robotics Inc.
  • 17.13. eCential Robotics
  • 17.14. EndoQuest Robotics, Inc.
  • 17.15. Globus Medical
  • 17.16. Intuitive Surgical, Inc.
  • 17.17. Johnson & Johnson Services. Inc.
  • 17.18. KUKA AG by Midea Group
  • 17.19. Medicaroid Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL ROBOTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL ROBOTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY GENERAL SURGERY ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY GENERAL SURGERY ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY GENERAL SURGERY ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY LAPAROSCOPIC ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY LAPAROSCOPIC ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY LAPAROSCOPIC ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY NEUROSURGICAL ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY NEUROSURGICAL ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY NEUROSURGICAL ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY ORTHOPEDIC ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY ORTHOPEDIC ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY ORTHOPEDIC ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY UROLOGICAL ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY UROLOGICAL ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY UROLOGICAL ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY TELEROBOTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY TELEROBOTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY TELEROBOTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY TETHERED / CONSOLE-BASED ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY TETHERED / CONSOLE-BASED ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY TETHERED / CONSOLE-BASED ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS SURGICAL ROBOTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GCC SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GCC SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 97. GCC SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. GCC SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. GCC SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 107. BRICS SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. G7 SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. G7 SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 112. G7 SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. G7 SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. G7 SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NATO SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NATO SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 117. NATO SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NATO SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. NATO SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. UNITED STATES SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. UNITED STATES SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 123. UNITED STATES SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. CHINA SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. CHINA SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. CHINA SURGICAL ROBOTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA SURGICAL ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA SURGICAL ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)